510(k) Report

510(k) · Cleared

Cleared

Aspirinworks Test Kit (11-Dehydro Thromboxane B2), Model 12136

K062025510(k) TraditionalCleared May 29, 2007315-day reviewClass II21 CFR 864.5700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Corgenix, Inc. · OBW 11-Dehydro Thromboxane B2 Kit, Urinary

Cleared on May 29, 2007 as substantially equivalent to K042423 (Accumetrics, Inc., 2004) after a 315-day review. Its family tree reaches back 2 generations to 1983.

Decided
May 29, 2007
Review
315 days
Class
Class II
Product code
OBW
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K830749 (1983). No later device cites it as a predicate yet.

  1. Root · 2 generations backK830749 Platelet AggregometerChrono-Log Corp. · 1983
  2. 1 generation backK042423 Verifynow-Aspirin AssayAccumetrics, Inc. · 2004
  3. This deviceK062025 Aspirinworks Test Kit (11-Dehydro Thromboxane B2), Model 12136Corgenix, Inc. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K830749Platelet AggregometerChrono-Log Corp.1983—
−1K042423Verifynow-Aspirin AssayAccumetrics, Inc.2004—
0 (this device)K062025Aspirinworks Test Kit (11-Dehydro Thromboxane B2), Model 12136Corgenix, Inc.2007—
FIG. 1 — Lineage of K062025, 1983–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042423Verifynow-Aspirin Assay
Summary page 1
…ification: 21 CFR 864 5700 Proposed Product Code: jo 0z L Predicate Device: VerifyNow~"' Aspirin Assay (K042423) Device Description: An ELISA for the detection of urinary 1I1-Dehydro Thromboxane B2 (I1 dhTxB 2). Goat anti-mouse IgG polyclon…
Accumetrics, Inc.2004—

Also cleared against K042423: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 21.4 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K042423.

How does its category compare?

All OBW devices

OBW 11-Dehydro Thromboxane B2 Kit, Urinary: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · OBW

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBW

Too few OBW 510(k)s in any year since 2007 to give a median.

Recalls per year · OBW

No recall names OBW since 2007.

Adverse event reports per year · OBW

2in 2023

2015: 12016: 32023: 2
2007high 3 (2016) · low 0 (2007)2025

MAUDE reports naming product code OBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—01
20160—03
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B 2 (I1 dhTxB 2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only. The AspirinWorks® Test Kit is intended for use in clinical (hospital and reference) laboratories. The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine…

Read the full statement (110 words)

The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B 2 (I1 dhTxB 2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only.

The AspirinWorks® Test Kit is intended for use in clinical (hospital and reference) laboratories.

The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B2 (1ldhTxB 2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only.

The AspirinWorks® Test Kit is intended for use in clinical (hospital and reference) laboratories.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062025: Aspirinworks Test Kit (11-Dehydro Thromboxane B2), Model 12136.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062025

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026